The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RVMD FINANCIAL STATEMENTS

Revolution Medicines Inc — balance sheet, income statement and cash flow trends

RVMDRevolution Medicines Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-1 B0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-9.2 M $ · -Infinity%Operating Income-1.6 B $ · -Infinity%Pre-tax Income-1.8 B $ · -Infinity%Net Income to Owners-1.8 B $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-9.2 M $—
Operating Income-1.6 B $—
EBITDA-1.7 B $—
Net Income to Owners-1.8 B $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets4.3 B
  • Equity2.6 B $60%
  • Current Liabilities354.1 M $8%
  • Long-term Liabilities1.4 B $32%

Key Figures

YoY change
Total Assets4.3 B $+77.9%
Total Liabilities1.7 B $+204.3%
Total Equity2.6 B $+39.7%
Cash & ST Investments3.9 B $+84.3%
Total Debt641.9 M $+383.4%
Net Debt-173.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-1.5 B-1 B-500 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-2 B-1 B0-1.6 B $Operating-1.2 B $Investing3.3 B $Financing471.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-1.6 B $—
Capital Expenditures10.6 M $-31.2%
Free Cash Flow-1.6 B $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RVMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.